Investor insights
Sectors invested in
Funding rounds participated in
$23M sweet spot round size
Most of their 42 investments are in rounds between $12M and $63M
Investor type
Basic info
Industry
Sectors
Date founded
2016
Investments made
Fore Biotherapeutics raised $75M on August 23, 2023
Investors: OrbiMed Advisors, S.R. One Ltd, 3B Future Health Fund, Wellington Management, HBM Partners AG and Medicxi
Aldena Therapeutics raised $30M on March 16, 2023
Investors: Medicxi
NewAmsterdam Pharma raised $235M on November 23, 2022
Investors: Life Sciences Partners (LSP), Forbion, Frazier Healthcare Partners, RA Capital Management, L.P., GMT Capital and Medicxi
Rivus Pharmaceuticals raised $132M on September 22, 2022
Investors: Longitude Capital, RA Capital Management, L.P. and Medicxi
MiroBio Ltd raised $97M on June 29, 2022
Investors: Monograph Capital, Oxford Sciences Innovation, OrbiMed Advisors, Advent Life Sciences, Samsara BioCapital, S.R. One Ltd and Medicxi
Xenikos B.V. raised $47M on September 8, 2021
Investors: Veloxis Pharmaceuticals, RA Capital Management, L.P., Oost NL and Medicxi
Versanis Bio raised $70M on August 31, 2021
Investors: Atlas Venture, Aditum Bio and Medicxi
Undisclosed raised $45M on August 10, 2021
Investors: SC Master Fund, Bluestem Capital Co, Longitude Capital, Visionary Venture Fund, RA Capital Management, L.P. and Medicxi
Rivus Pharmaceuticals raised $35M on July 20, 2021
Investors: Longitude Capital and Medicxi
Kurome Therapeutics, Inc. raised $15M on June 10, 2021
Investors: Queen City Angels, CincyTech USA, Affinity Asset Advisors and Medicxi